Menarini Silicon Biosystems
Ralf Schoenbrunner is currently the Chief Global R&D Officer at Menarini Silicon Biosystems since September 2020. Previously, Ralf served as Chief Technology Officer at SCIEX, where responsibilities included establishing technology vision and growth strategies. Ralf held the position of Vice President in Research & Development at PerkinElmer, focusing on diagnostics, and was the Vice President, Global Head of Diagnostics Development at Novartis, leading a team in developing companion diagnostic assays. Earlier roles included Senior Vice President at diaDexus, Vice President at Life Technologies in Medical Sciences and Molecular Diagnostics, and participation as a corporate officer at Acrometrix, overseeing product strategy and R&D. Ralf's career began at Roche Molecular Systems, excelling in the development of complex assays. Ralf holds a Ph.D. in Physical Biochemistry from the University of Bayreuth, along with two Master's degrees from the University of Regensburg and the University of Edinburgh.
This person is not in any offices
Menarini Silicon Biosystems
1 followers
Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization. The company’s CELLSEARCH® and DEPArray™ technologies together provide an end-to-end solution for enumeration and sorting of rare cells with single-cell precision. Menarini Silicon Biosystems, based in Bologna, Italy, and Huntingdon Valley, PA, US, is a wholly-owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology, and diagnostics company headquartered in Florence, Italy, with 17,640 employees in 136 countries. Read our Netiquette here: www.siliconbiosystems.com/netiquette